By Bill Berkrot (Reuters) - Amgen Inc on Monday reported higher-than-expected third quarter earnings and revenue, even as net profit fell due to a hefty restructuring charge, and the company raised its full-year forecast and the number of job cuts it expects to make. The world's largest biotechnology company recorded a $376 million charge related to restructuring moves announced July 29 and expects to take another charge of up to $150 million in the fourth quarter, as well as additional charges next year. Amgen shares rose 1 percent. ...
via Health News Headlines - Yahoo News Read More Here..
No comments:
Post a Comment